Company / Gross Profit per Share
Biogen Gross Profit per Share History
FY2016-FY2020 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit per Share
$59.02
FY2020
5-year range
-
FY2016-FY2020
Trend
+0.5%
vs FY2019
Sector context
#2 of 27
Health Care
What the data says
Among 27 Health Care companies, Biogen is in the top 7% for gross profit per share. Gross Profit per Share has increased for 4 consecutive years, from $45.61 in FY2016 to $59.02 in FY2020.
Based on SEC 10-K filings.
59.02 in FY2020 with a 3-year CAGR of +6.2%. Ranks 2nd among 27 companies in Health Care.
Improved from $53.90 to $59.02 over the past 2 years.
Health Care sector context is included.
Gross Profit per Share over time
Growth rates
- 3-Year CAGR
- +6.2%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 7% in Health CareTop 7% of 27This company $59.02 Sector average $8.24
▼
+616.2% above sector average
Key checks
Key Insights
- Biogen's gross profit per share has grown for 4 consecutive years.
- In FY2020, gross profit per share increased 0.5% year-over-year.
- Ranks #2 out of 27 companies in the Health Care sector.
- Lowest gross profit per share in the period was in FY2016.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross Profit per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | $59.02 | +0.5% |
| FY2019 | $58.74 | +9.0% |
| FY2018 | $53.90 | +9.3% |
| FY2017 | $49.30 | +8.1% |
| FY2016 | $45.61 | +12.4% |
As of FY2020 · SEC 10-K · Updated Mar 3, 2026